Marantz Jing L. bought NTLA
October 26, 2026 · Form 4 insider transaction
Marantz Jing L. bought 199,822 shares of Intellia Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
199,822
Price
$0.00
Total value
N/A
InsiderMarantz Jing L.
RoleOfficer
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateOctober 26, 2026
Filing dateOctober 28, 2026
Shares owned after199,822
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Based on a grant of restricted stock units representing a contingent right to receive one share of Intellia common stock for each restricted stock unit.